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Here we present a review of most of the currently used 
polymerase chain reaction (PCR)-based methods for iden-
tification of Brucella bacteria in biological samples. We fo-
cused in particular on methods using single-pair primers, 
multiplex primers, real-time PCRs, PCRs for marine Brucella, 
and PCRs for molecular biotyping. These methods are be-
coming very important tools for the identification of Bru-
cella, at the species level and recently also at the biovar 
level. These techniques require minimum biological con-
tainment and can provide results in a very short time. In 
addition, genetic fingerprinting of isolates aid in epidemi-
ological studies of the disease and its control. PCR-based 
methods are more useful and practical than conventional 
methods used to identify Brucella spp., and new methods 
for Brucella spp. identification and typing are still being de-
veloped. However, the sensitivity, specificity, and issues of 
quality control and quality assurance using these methods 
must be fully validated on clinical samples before PCR can 
be used in routine laboratory testing for brucellosis.
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Review of Detection of Brucella 
spp. by Polymerase Chain 
Reaction
Brucellosis is caused by Brucella spp. which is composed of 
eight terrestrial species and at least two marine species. Ter-
restrial Brucella spp. include B. abortus, B. melitensis, B. suis. 
B. ovis, B. canis, B. neotomae, and two new species, B. microti 
and B. inopinata. Brucella isolated from marine mammals 
are B. ceti and B. pinnipedialis (1). The first 3 terrestrial spe-
cies include several biovars. The terrestrial Brucella species 
display a high degree of DNA homology based on DNA-
DNA hybridization studies. Nevertheless, DNA polymor-
phism sufficient to differentiate the first 6 Brucella species 
and some of their biovars has been shown to exist (2). Bru-
cella isolated from marine mammalian species is still un-
der investigation. According to the classical criteria of host 
preference and DNA polymorphism at their outer mem-
brane protein 2 (omp2) locus, at least 2 species that infect 
marine mammals exist (3).
The gold standard for the diagnosis of brucellosis is isola-
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teria is time- and resource-intensive; it requires level 3 
biocontainment facilities and highly skilled technical per-
sonnel to handle samples and live bacteria for eventual 
identification and biotyping. Handling all live Brucella in-
volves risk of laboratory infection and very strict biosafety 
rules must be observed. In order to avoid these disadvan-
tages, methods based on the polymerase chain reaction 
(PCR) are becoming very useful and considerable progress 
has been made recently to improve their sensitivity, speci-
ficity, and technical ease and to lower costs. To date, at 
least 400 reports have been published dealing with various 
PCR-based methods for Brucellosis detection. In this review, 
we discuss extraction of DNA and various PCR methods us-
ing different primers and reaction conditions.
PCR-based methods aNd moLeCuLaR diagNosis 
of bRuCeLLosis
1. extraction of dNa from brucella
Extraction of DNA is the first step in performing any PCR. 
Standardized procotols for DNA extraction exist (4,5) or 
commercial kits may be used, such as the FlexiGen DNA 
kit form QIAGEN (Hilden, Germany) and the DNA isola-
tion kit for mammalian blood from Roche Applied Sci-
ence (Laval, Quebec, Canada). Primary cultures of Brucella 
can be tested directly. The test samples from which DNA 
can be extracted most commonly for brucellosis diagno-
sis include tissues from neonates or aborted fetuses, milk, 
whole blood, serum, semen, body fluids, and foods such as 
cheese. Some samples are easily obtained from animals for 
DNA extraction, including milk and blood. For instance, an 
improved method for purification of bacterial DNA from 
bovine milk for detection of Brucella spp. by PCR has been 
reported (6). This method uses a lysis buffer with high con-
centrations of trishydroxymethylaminomethane, ethylene 
diamine tetraacetic acid disodium salt dehydrate (EDTA), 
and sodium chloride, high concentrations of sodium do-
decyl sulfate, and proteinase K, and a high incubation tem-
perature for the efficient extraction of Brucella DNA. The 
sensitivity of the PCR was 5 to 50 Brucella colony forming 
units (CFU)/mL of milk (6).
Blood samples are often used in PCR-based diagnosis of 
human brucellosis (7,8). However, inhibitors frequently af-
fect PCR results (9). Washing the blood a few times with 
water or lysis buffer until all the hemoglobin disappears 
before extracting the DNA increases the PCR sensitivity 
substantially (10). A PCR method that incorporates this 
washing procedure, a higher number of PCR cycles (40 cy-
cles instead of 35), and primers for the gene encoding the 
Brucella cell surface salt-extractable (BCSP) 31-kDa protein 
can detect 700 CFU/mL of peripheral blood (11).
Serum samples are often used for extraction of DNA for 
PCRs. One study compared the relative recovery of bacte-
rial DNA extracted from human serum spiked with known 
concentrations of B. melitensis Rev 1. Seven commercial 
kits were examined: UltraClean DNA BloodSpin Kit (MO 
BIO, Carlsbad, CA, USA), Puregene DNA Purification System 
(Gentra Minneapolis, MN, USA), Wizard Genomic DNA Pu-
rification Kit (Promega, Madison, WI, USA), High Pure PCR 
Template Preparation Kit (Roche), GFX Genomic Blood 
DNA Purification Kit (GE Healthcare, Little Chalfont, UK), 
NucleoSpin Tissue Kit (Macherey-Nagel, Düren, Germany), 
and QIAamp DNA Blood Mini Kit (Qiagen) (12). These com-
mercial kits were compared with a genus-specific real-time 
PCR method. The study revealed that some kits were more 
sensitive than others and that the most efficient kits could 
isolate sufficient DNA for detection of as little as 100 fg of 
Brucella DNA, in some cases without any contamination. 
The other procedures yielded DNA isolation results that 
were less sensitive and the negative samples were always 
contaminated with Brucella DNA. The results show that 
commercial extraction kits are capable of extracting low 
amounts of relatively pure Brucella DNA from animal se-
rum (12).
Another commercial product for DNA extraction is the FTA 
paper card (Whatman; Maidstone, UK). Quantification of 
DNA from EDTA-animal blood deposited on an FTA card 
was shown to be accurate and reproducible (13). The re-
sults also showed that fractions of recipient cell DNA de-
tected by real-time reverse transcription-PCR were similar 
between the FTA and a salting-out method, the standard 
DNA extraction method. Furthermore, the two methods 
showed similar sensitivity of detection of recipient cells 
(13). FTA cards have more recently been used for DNA ex-
traction from body fluids (unpublished data, cited in 13). 
Tests showed that Brucella DNA was isolated with good 
yield, but the sensitivity of the method was not deter-
mined.
2. single pairs of PCR primers
Primer pairs used to identify Brucella spp. at the genus-spe-
cific level include the primers for sequences encoding BCSP 
31(B4/B5) (14), 16SrRNA(F4/R2) (15), 16s-23S 16S–23S in-
tergenic transcribed spacers (ITS) (Bru ITS-S/Bru ITS-A) 
(16,17), 16S-23S rDNA interspace (ITS66/ITS279) (18), 
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IS711 (IS313/IS639) (19), per (bruc1/bruc5) (20), omp2 (JPF/
JPR) (21), outer membrane proteins (omp 2b, omp2a and 
omp31) (22), proteins of the omp25/omp31 family of Bru-
cella spp. (23), and arbitrary primers (24). The sensitivity and 
specificity vary substantially for the different pairs of primers. 
Primers B4 and B5 targeting BCSP 31 are often used for hu-
man brucellosis diagnosis. If combined with an increase in 
cycle numbers, this pair of primers can provide the greatest 
sensitivity when testing human blood samples (11).
A study (25) analyzed the sensitivity and specificity of the 3 
established genus-specific PCR methods targeting bcsp31, 
omp2 and 16S rRNA gene sequences, and it also compared 
their efficiencies for the simple detection of the Brucella 
genus directly from blood samples in a large-scale screen-
ing of individual animals from seropositive Indian field buf-
falo and cattle herds. The results showed that the 16S rRNA 
gene used for detection of bovine blood samples was in-
sensitive. The bcsp31 PCR was the most sensitive: it had a 
sensitivity similar to that obtained using the combination 
of omp2 blood PCR and ELISA. The use of more than one 
marker-based PCR gave increased sensitivity and high-
er specificity providing a better molecular diagnostic ap-
proach for screening of field animals.
Recently, a combined PCR has been applied to detect Bru-
cella spp. at the genus level. Four pairs of primers derived 
from bcsp31 and outer membrane proteins (omp2b, om-
p2a, omp31) were used in 4 individual PCRs in different 
combinations to identify B. abortus, B. melitensis, B. canis, 
and B. suis (22). These PCRs were shown to be ideal meth-
ods for detection of human brucellosis.
A novel PCR assay for the rapid detection of members of 
the Brucella genus that could differentiate among the 6 
recognized Brucella species (excluding B. microti) in 7 sin-
gle PCR reactions has been described (26). The assay was 
shown to be highly specific, with the additional advantage 
of being suitable for both conventional and real-time PCR 
formats. The only disadvantage was the similarity of the 
PCR patterns for B. suis biotype 4 and B. canis (2).
In some geographic areas, one species of Brucella may be 
more prevalent than others. Some PCRs have been devel-
oped to differentiate and identify Brucella biotypes. One 
such PCR can separate B. abortus biovars 1, 2, and 4 from 
other Brucella species (27).
Brucella abortus strain S19 and B. abortus strain RB51 are 
used as vaccines for cattle. Therefore, it is very im-
portant to be able to identify and differentiate these vac-
cine strains from pathogenic B. abortus strains. One pair of 
primers based on sequences of the ery locus was used to 
identify S19 (28), while an RB51-specific PCR was used to 
identify vaccine RB51 from other Brucella species using dif-
ferentiation based on wboA gene mutations (29).
3. multiplex PCRs
Several multiplex PCRs have been described for identifica-
tion of Brucella at the species level and partly at the biovar 
level using different primer combinations. The first multi-
plex PCR, called AMOS PCR for Brucella abortus, B. melitensis, 
B. ovis, and B. suis, was published in 1994. It used five prim-
ers to identify Brucella at the species level (30). This method 
could detect selected biovars of 4 species of Brucella; bi-
ovars 1, 2, and 4 of B. abortus; all 3 biovars of B. melitensis; bi-
ovar 1 of B. suis; and biovar 1 of B. ovis. This assay could not 
differentiate individual biovars within a species. The PCR 
was used to evaluate animal field samples and was found 
to be in 100% agreement with the conventional biotyping 
methods. In order to distinguish B. abortus vaccine strains 
S19 and RB51 from field strain isolates, 3 additional prim-
ers were added to the original AMOS PCR (31). The eight 
primer mixtures could differentiate most of Brucella strains 
expected to occur in the US. Based on this AMOS PCR for-
mat, another primer was designed and added. This refined 
AMOS PCR produced an extra band found only in B. abor-
tus biovars 3b, 5, 6 and 9 (32).
An improved PCR, the B. abortus species-specific PCR, was 
subsequently used to specifically recognize field strains of B. 
abortus biovars 1, 2, and 4, which were the only biovars oc-
curring in the US. This method was also used with bovine tis-
sue samples to distinguish the aforementioned strains from 
vaccine strains, other Brucella species, and Brucella-related or 
-unrelated bacteria that might give cross reactions (33). Bru-
cella suis biovars 1, 2, and 3 were identified by a multiplex 
PCR, which included primers based on sequence variation 
of the omp2b gene. However, the use of this PCR was limited 
because the B. suis biovar 1 pattern produced from animal 
field isolates of B. suis was similar to that of B. suis biovars 2 
and 3, based on identification by bacteriological methods 
(34). A multiplex PCR using 8 multi-locus variable number 
tandem repeat analysis (MLVA) primers was able to distin-
guish B. melitensis from other Brucella species and allowed 
strain typing (35). This method was used to identify 7 epide-
miologically-linked clusters of B. melitensis and the source of 
a laboratory-acquired infection. The assay was found to be 
practical for technical and economical reasons.
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More recently, a multiplex PCR assay (Bruce-ladder) has been 
used to identify all Brucella sp. at genus level, including 6 ter-
restrial species, the marine species of Brucella, and the vac-
cine strains S19, RB51, and Rev. 1 (36). Based on the Bruce-
ladder PCR, an improved multiplex PCR was developed that 
differentiates all 9 currently recognized Brucella species, in-
cluding the recently described species B. microti, B. inopinata, 
B. ceti and B. pinnipedialis. The method was used to identify all 
known Brucella strains and their biotypes in one test (37).
A new PCR-based test method, random amplified poly-
morphic DNA PCR, was performed to identify primers for 
differentiating Brucella at the species and biovar levels 
(38). Based on the results, 19 primers were used to devel-
op a multiplex PCR. This multiplex PCR method specifically 
identified B. neotomae, B. pinnipedialis, B. ceti, and B. microti. 
The assay also differentiated B. abortus biovars 1, 2, 4 from 
biovars 3, 5, 6, 9; futhermore, it differentiated among B. suis 
biovar 1, biovars 3 and 4, and biovars 2 and 5. This meth-
od gave identical results to previous typing for all Brucella 
types and reference strains and for the majority of 118 field 
strains. One group of B. canis strains exhibited a unique pat-
tern, while a second group produced the same pattern as 
B. suis biovars 3 and 4. No cross reactions were detected.
4. Real-time PCR
Real-time PCR has recently been developed (39-41). The 
major advantages of real-time PCR are that it can be per-
formed in a very short time, does not require electropho-
retic analysis, and avoids contamination. The samples that 
can be tested by real-time PCR include cultured Brucella 
cells (39), serum (40), blood, and paraffin-embedded tis-
sues (41). Real-time PCRs can be used for the diagnosis of 
human brucellosis and discriminated among inactive, se-
ropositive, and active states when it was used to test se-
rum samples for which clinical findings were known (41). In 
an extension of the AMOS PCR, 3 separate real-time PCRs 
were developed to specifically identify B. abortus biovars, B. 
melitensis, and B. suis at the species level using fluorescence 
resonance energy transfer (39). The upstream primers used 
in these real-time PCRs were from insertion sequence 
711; the downstream primers and adjacent hybridization 
probes were species-specific. The real-time PCR was com-
plete in about 30 minutes and it was specific and sensitive 
based on evaluation of reference and field strains.
A real-time PCR using primers B4 and B5 primers (targeting 
bspc31) and SYBR Green I to diagnose brucellosis at genus 
level was compared with PCR-enzyme-linked immunosor-
bent assay (40). This method was applied to blood cultures 
of serum samples and to whole blood samples in human 
brucellosis cases. The results showed that real-time PCR ap-
plied to serum samples was more sensitive than other meth-
ods. A quantitative real-time PCR with primers and a Taqman 
probe of bcsp31 was developed to differentiate inactive, se-
ropositive, and active human brucellosis in serum samples. 
The results showed that the sensitivity was 10 fg of Brucella 
DNA and was useful for both initial diagnosis and differentia-
tion between chronic and active brucellosis (42).
Three real-time PCRs for diagnosis of human brucellosis 
at genus level were developed and evaluated with whole 
blood and paraffin-embedded tissues (41). The primers 
and adjacent hybridization probes were from 16S-23S ITS, 
omp25 and omp31. According to the results, real-time PCR 
with 16S-23S ITS primers and its probes was the most sen-
sitive and could be used for the diagnosis of human bru-
cellosis in the clinical laboratory.
One study compared real-time PCRs to identify Brucella spp. 
at genus level using primers and TaqMan probes targeting 
the IS711, bcsp31 and per genes. The results showed that the 
IS711-based assay was the most sensitive, specific, efficient, 
and reproducible method to detect Brucella spp. (43).
Novel primers and TaqMan probes specific for the 6 clas-
sic Brucella spp. were designed and the primers used for 
6 single real-time and conventional PCRs to identify and 
differentiate Brucella spp. at the species level. These PCRs 
were verified to be highly specific and suitable for use with 
real-time and conventional PCRs (27).
Four single real-time PCRs used to identify and differenti-
ate B. suis at biovar level were developed based on prim-
ers and TaqMan probes capable of discriminating 4 single 
nucleotide polymorphisms. The results showed that allelic 
profiles were unique for each B. suis biovar and the most 
relevant signatures of 137 field strains of worldwide origin 
characterized previously were collected and verified with 
real-time PCRs. One disadvantage of the real-time PCRs 
was that some B. suis biovar 3 field strains matched the al-
lelic profile of B. suis biovar 1 (44).
5. PCRs for marine species of brucella
In recent years, marine mammal Brucella species have been 
found in diverse sea mammals (45). Phylogenetic trees 
constructed based on the omp2b sequence showed 
divergence between omp2b and between omp2a 
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nucleotide sequences, indicating that marine mammal 
Brucella isolates form a more heterogeneous group than 
do isolates from terrestrial mammals. Analyses combining 
infrequent restriction site (IRS)-derivative PCR, restriction 
enzyme digestion (RFLP), -PCR of outer membrane protein 
genes, and IS711 fingerprint profiles to analyze Brucella 
originating from 11 species of marine mammals showed 
that isolates originating from cetaceans, corresponding to 
B. ceti, fell into two clusters that corresponded to isolates 
from either dolphins (cluster 3 or ISR-PCR IV) or porpoises 
(cluster 2 or ISR-PCR II, III). Their preferred host and isolates 
from seals fell into another major group (cluster 1 or ISR-
PCR I), corresponding to B. pinnipedialis. This major group 
was further subdivided (cluster 4 or ISR-PCR I), with isolates 
from hooded seals making up a distinct group (46). Based 
on analysis of 45 marine mammal isolates with the mul-
tilocus sequencing method, 5 sequence types (ST) were 
found and labeled ST23 to ST27. ST 23 was predominantly 
associated with porpoises; ST26 was isolated from dolphin 
species only; ST24 and ST25 were largely associated with 
seals. ST27 was isolated only once from a bottlenose dol-
phin and was more closely related to the seal STs than to 
those associated with porpoises and dolphins (47).
A PCR was designed to discriminate all terrestrial Brucella, in-
cluding B. ovis, from Brucella sp. isolated from marine mam-
mals (48). The method uses primers A26 and B26, which 
amplify the entire bp26 gene and its flanking sequences 
using the IS711 element downstream of the bp26 gene as 
a specific marker. Subsequently, specific PCRs were devel-
oped based on infrequent restriction site-PCR. Using spe-
cific PCRs I, II, III, IV, Brucella sp. from marine mammals was 
divided into 4 groups. Samples positive for specific PCR I 
were B. pinnipediae strain B2/94 (common seal); those posi-
tive for specific PCR II and III were B. cetaceae (now identi-
fied as B. ceti) strain B1/94 (porpoise); and those positive 
for specific PCR IV were B. ceti strains B14/94 (49). All these 
PCR results match the results obtained using IRS-derivative 
PCR, PCR-RFLP of outer membrane protein genes (omp), 
and IS711 fingerprint profiles (46). Specific V and VI PCRs 
were developed according to specific IRS-PCR fragments 
of the marine mammal Brucella isolates. These PCRs were 
specific for B. pinnipedialis strains. The strains from marine 
mammals which were positive for specific PCRs I and VI 
were also positive for specific PCR V (50).
6. molecular biotyping
There are a number of methods for genotyping Brucel-
la strains. However, most were limited to use with 
livestock isolates until hypervariable octameric oligonu-
cleotide fingerprints (“HOOF-Prints”) technology was de-
veloped (51). The HOOF-Print method used variable num-
ber tandem repeats of the DNA sequence “AGGGCAGT” 
at 8 loci in the genome of Brucella to identify the spe-
cific alleles at each of the repeat loci. The PCR products 
are analyzed by Metaphor agarose gel and fluorescence 
tagged capillary electrophoresis. After verifying the clas-
sical Brucella species and biovars, field strains from infect-
ed cattle and wildlife herds were examined. The meth-
od was able to discriminate all species and biovars and 
field strains. This method was as rapid as other methods 
and the results were reproducible. One disadvantage was 
that no species- or biovar-specific alleles were found and 
it could therefore be used only after identification by oth-
er methods. More recently, a Brucella MLVA-15 typing as-
say was developed (52). The 15 markers were divided into 
two panels. Panel 1 included 8 user-friendly minisatel-
lite markers with good species identification capabilities. 
Panel 2 had 7 microsatellite markers with higher discrimi-
natory power.
Twenty one variable number tandem repeat markers 
were used for typing Brucella spp. including 8 pairs of 
HOOF-PCR primers (53). The results showed that 6 loci 
were sufficient to determine the species designation. 
When more variable loci were analyzed, the assay was 
able to discriminate isolates originating from some dif-
ferent geographical sources. This method has great po-
tential for further development and application to both 
epidemiological tracing of Brucella spp. transmissions 
and in determining the relationship among isolates 
worldwide (53).
The methods for characterization of the genetic diversity 
of Brucella spp. include multilocus sequencing (54). Meth-
ods for identification of Brucella spp. include multiplex as-
says based on single-nucleotide polymorphisms identi-
fying the major Brucella spp. isolates at the species level 
(55), real-time PCR of single-nucleotide polymorphisms 
defining the major Brucella spp. clades for distinguish-
ing bacteria with clonally derived population structures 
(56), and rapid identification of Brucella spp. isolates at 
the species level by real-time PCR-based single-nucleo-
tide polymorphism analysis (57). All these methods are 
somewhat more complicated than other PCR methods 
and require special equipment, making them of limited 
use in the diagnostic laboratory. Additional time is need-
ed to streamline and adapt these methods for use with 
diagnostic samples.
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CoNCLusioN
The gold standard for diagnosis of Brucellosis remains iso-
lation of Brucella spp. bacteria from samples. However, 
PCR-based methods that identify nucleic acid fragments 
from the bacteria are more useful and practical. Most of the 
new methods for Brucella spp. identification and typing are 
still being developed and still await validation for use with 
clinical samples. This is especially true for PCR tests target-
ing new species of Brucella spp. from marine mammals.
Most of these PCR-based methods were developed using 
Brucella spp. DNA prepared directly from cultured bacteria 
or extracted from the culture. The quality and purity of Bru-
cella spp. DNA is very important in performing these meth-
ods, especially for multiplex PCR methods. Any inhibitor in 
DNA samples from any sources may limit the use of these 
methods. False-negative reactions can occur through a 
number of mechanisms such as specimens that contain 
EDTA, RNase or DNase, heme, heparin, phenol, polyamines, 
plant polysaccharides, urine, calcium alginate, and proba-
bly a host of other reagents. False-positive reactions result-
ing from specimen contamination or amplicon carryover 
also require attention (58).
The sensitivity and specificity of most PCR-based methods 
are not well established and their real value for use with 
clinical samples and hence diagnosis has not been vali-
dated. There is still a great deal of work required for verifi-
cation, validation, establishment of standard positive and 
negative controls, internal and inhibition control, reagents, 
quality assurance, and contamination before any of these 
methods may be used in routine laboratory testing for bru-
cellosis (59).
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